XML 62 R45.htm IDEA: XBRL DOCUMENT v3.22.4

Loss per Common Share (Tables)

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):

									For the Year Ended December 31,
															2022						2021						2020
Loss from continuing operations															$	(18,701)					$	(30,284)					$	(328,172)
Loss from discontinued operations, net of tax															(463)						(7,317)						(6,074)
Net loss attributable to common shareholders of Evolent Health, Inc.															$	(19,164)					$	(37,601)					$	(334,246)
Weighted-average common shares outstanding - basic and diluted															93,699						86,067						84,928
Loss per common share
Basic and diluted
Continuing operations															$	(0.20)					$	(0.35)					$	(3.86)
Discontinued operations															—						(0.09)						(0.08)
Basic and diluted loss per share attributable to common shareholders of Evolent Health, Inc.															$	(0.20)					$	(0.44)					$	(3.94)

Basic net loss per common share is calculated using the weighted average number of common shares outstanding during the period. Diluted net earnings per common share, if any, gives effect to diluted stock options (calculated based on the treasury stock method), shares issuable upon debt conversion (calculated using an as-if converted method).

Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share

Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):

									For the Year Ended December 31,
															2022						2021						2020
Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs")															1,804						1,807						797
Stock options															1,769						2,036						1,141
Convertible senior notes															9,574						12,602						11,206
Total															13,147						16,445						13,144

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration